Research Topics
| Evelyne ReySummaryCountry: Canada Publications
| Collaborators
|
Detail Information
Publications
Thrombophilic disorders and fetal loss: a meta-analysisEvelyne Rey
Department of Obstetrics and Gynecology, Sainte Justine Hospital, Quebec, Montreal, Canada
Lancet 361:901-8. 2003..Our aim was to assess the strength of the controversial association between thrombophilia and fetal loss, and to examine whether it varies according to the timing or definition of fetal loss...
Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trialE Rey
Division of Obstetrics Medicine, Department of Obstetrics and Gynaecology, CHU Sainte Justine, Montreal, QC, Canada
J Thromb Haemost 7:58-64. 2009..The role of anticoagulants for the prevention of placental-mediated pregnancy complications is uncertain...- [Postpartum compliance to oral glucose tolerance test]E Rey
Service de Médecine Obstétricale, Département d Obstétrique et Gynécologie, Hopital Sainte Justine, Universite de Montreal, Montreal, Canada
J Gynecol Obstet Biol Reprod (Paris) 36:281-6. 2007..The secondary objective is to determine factors associated to non-adherence to GTT... 
Asthma in pregnancyEvelyne Rey
Departments of Medicine and Obstetrics and Gynaecology, Faculty of Medicine, University of Montreal, CHU Ste-Justine, , Montreal, QC, Canada H3T 1C5
BMJ 334:582-5. 2007- Blood pressure assessments in different subtypes of hypertensive pregnant women: office versus home patient- or nurse-measured blood pressureEvelyne Rey
CHU Sainte Justine, Obstetrics and Gynecology, Montreal, Quebec, Canada
Hypertens Pregnancy 28:168-77. 2009..To explore the difference between distinct methods of assessing blood pressure (BP) in pregnant women with different hypertensive disorders... - Is testing for aspirin response worthwhile in high-risk pregnancy?Evelyne Rey
Division of Obstetric Medicine, Department of Obstetrics and Gynecology, CHU Sainte Justine, 3175 Cote Sainte Catherine, Montreal, QC, Canada H3T 1C5
Eur J Obstet Gynecol Reprod Biol 157:38-42. 2011..To explore the clinical impact of aspirin dosage adjustment in pregnant women at high risk of hypertensive disorders... - Fasting plasma glucose versus glucose challenge test: screening for gestational diabetes and cost effectivenessEvelyne Rey
Department of Obstetrics and Gynecology, Sainte Justine Hospital, Montreal, QC, H3T 1C5, Canada
Clin Biochem 37:780-4. 2004..To compare the performance in screening for gestational carbohydrate intolerance of the 1-h 50-g glucose challenge test (GCT), fasting plasma glucose (FPG) and fasting capillary glucose (FCG)... - Home blood pressure levels in pregnant women with chronic hypertensionEvelyne Rey
Internal Medicine Service, Department of Obstetrics and Gynaecology, CHU Sainte Justine and Université de Montréal, Montreal, Canada
Hypertens Pregnancy 26:403-14. 2007..To explore the difference between office and home blood pressure (BP) monitoring in normotensive and hypertensive pregnant women... - Maternal asthma, its control and severity in pregnancy, and the incidence of atopic dermatitis and allergic rhinitis in the offspringMarie Josée Martel
Faculty of Pharmacy, Universite de Montreal, Montreal, Quebec, Canada
J Pediatr 155:707-13.e1. 2009..To evaluate the relationship between maternal asthma, its level of control and severity during pregnancy, and atopic dermatitis (AD) and allergic rhinitis (AR) incidence in children... - Use of short-acting beta2-agonists during pregnancy and the risk of pregnancy-induced hypertensionMarie Josée Martel
Universite de Montreal, C P 6128, Succursale Centre Ville, Montreal, Quebec H3C 3J7, Canada
J Allergy Clin Immunol 119:576-82. 2007..After the finding of a possible protective association of inhaled SABAs with pregnancy-induced hypertension (PIH) in a previous study, we decided to further investigate their effect on this condition... - Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancyMarie Claude Breton
Faculty of Pharmacy, Universite de Montreal, Succursale Centre Ville, Montreal, Quebec, Canada
J Allergy Clin Immunol 126:772-777.e2. 2010..These studies must be interpreted with caution because they have insufficient statistical power and a lack of adjustment for potential confounders... - Determinants of the incidence of childhood asthma: a two-stage case-control studyMarie Josée Martel
Faculty of Pharmacy, Universite de Montreal, Montreal, Quebec, Canada
Am J Epidemiol 169:195-205. 2009..This study allowed the authors to identify, within a single setting, the most influential determinants of childhood asthma among 47 predictors assessed for the prenatal, perinatal, and childhood periods... - Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthmaLucie Blais
Universite de Montreal, Faculte de Pharmacie, CP 6128, Succursale Centre Ville, Montreal, Quebec, Canada H3C 3J7
Thorax 62:320-8. 2007..To investigate whether the maternal use of different doses of inhaled corticosteroids (ICSs) during the first trimester of pregnancy for the treatment of asthma increases the risk of congenital malformations in the offspring... - Duration of antidepressant use during pregnancy and risk of major congenital malformationsElodie Ramos
University of Montreal, and Research Center, Centre Hospitalier Universitaire CHU Sainte Justine, Montreal, QC, Canada
Br J Psychiatry 192:344-50. 2008..Antidepressant use during the gestational period is a controversial topic... - Determinants of early medical management of nausea and vomiting of pregnancyAnaïs Lacasse
Faculty of Pharmacy at the University of Montreal, Montreal, Quebec, Canada
Birth 36:70-7. 2009.... - Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the importance of race/ethnicityAnaïs Lacasse
Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
BMC Pregnancy Childbirth 9:26. 2009.... - Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertensionHamid Reza Nakhai-Pour
University of Montreal, Montreal, Quebec, Canada
Am J Obstet Gynecol 201:180.e1-8. 2009..The goal of this study was to investigate the association between the discontinuation of antihypertensive medication use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia... - Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophiliaLine Leduc
Department of Obstetrics and Gynecology, Sainte Justine Hospital, University of Montreal, Montreal QC
J Obstet Gynaecol Can 29:787-93. 2007..To evaluate the benefit of treatment with dalteparin and low-dose aspirin (ASA) in the prevention of obstetric complications in women with inherited thrombophilia... - Pregnancy outcomes in women with and without gestational diabetes mellitus according to the International Association of the Diabetes and Pregnancy Study Groups criteriaSonja Bodmer-Roy
Department of Obstetrics and Gynecology, University of Montreal, Montreal, Quebec, Canada
Obstet Gynecol 120:746-52. 2012.... - Risk of perinatal mortality associated with asthma during pregnancy: a 2-stage sampling cohort studyMarie Claude Breton
Faculty of Pharmacy, Universite de Montreal, Research Center, Hopital du Sacre Coeur de Montreal, Montreal, Quebec, Canada
Ann Allergy Asthma Immunol 105:211-7. 2010..However, these studies have methodologic limitations, such as lack of adjustment for cigarette smoking, a major risk factor for perinatal mortality... 
Risk of congenital anomalies in pregnant users of statin drugsBenjamin Ofori
Research Center, CHU Sainte Justine, Montreal, Quebec, Canada
Br J Clin Pharmacol 64:496-509. 2007..Evidence from animal studies suggests that statin medications should not be taken during pregnancy. Our aim was to examine the association between the use of statins in early pregnancy and the incidence of congenital anomalies...- Prevention of adverse pregnancy outcomes with low-dose ASA in early pregnancy: new perspectives for future randomized trialsEmmanuel Bujold
Department of Obstetrics and Gynecology, Faculty of Medicine, Universite Laval, Quebec, QC
J Obstet Gynaecol Can 33:480-3. 2011.... - Use of inhaled corticosteroids during pregnancy and risk of pregnancy induced hypertension: nested case-control studyMarie Josée Martel
Faculty of Pharmacy, Universite de Montreal, CP 6128, Succursale Centre Ville, Montreal, QC, Canada H3C 3J7
BMJ 330:230. 2005..To determine whether the use of inhaled corticosteroids during pregnancy increases the risk of pregnancy induced hypertension and pre-eclampsia among asthmatic women... - Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous womenFrancois Audibert
Department of Obstetrics and Gynecology, CHU Sainte Justine Research Center, Universite de Montreal, Montreal, Canada
Am J Obstet Gynecol 203:383.e1-8. 2010..To evaluate the screening accuracy of pregnancy hypertensive disorders by maternal serum biomarkers and uterine artery Doppler in the first trimester... - First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosageAnick Berard
Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
Birth Defects Res B Dev Reprod Toxicol 80:18-27. 2007.... - Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysisLucie Opatrny
Division of Clinical Epidemiology, McGill University Hospital Center, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, Quebec, Canada
J Rheumatol 33:2214-21. 2006.... - Preeclampsia: should plasma albumin level be a criterion for severity?Janie Benoit
Department of Obstetrics and Gynecology, University of Montreal, Montreal QC
J Obstet Gynaecol Can 33:922-6. 2011..To determine whether plasma albumin level (ALB) is associated with preeclampsia (PE) complications and to define its role in the evaluation of the severity of PE... - Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancyAnaïs Lacasse
Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada
Am J Obstet Gynecol 198:71.e1-7. 2008.... - Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control studyBenjamin Ofori
Research Center, Sainte-Justine Hospital, Montreal, Quebec, Canada
Birth Defects Res B Dev Reprod Toxicol 77:268-79. 2006..CONCLUSIONS: Our study suggests that women prescribed NSAIDs during early pregnancy may be at a greater risk of having children with congenital anomalies, specifically cardiac septal defects... - The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trialKarim Abou Nassar
The Ottawa Hospital, General Campus, 501 Smyth Road, Box 201, Ottawa, ONT K1H 8L6, Canada
Thromb Haemost 98:163-71. 2007..Prophylaxis with dalteparin at doses used in this study did not reduce coagulation activation in high risk thrombophilic women during pregnancy...